Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New combo therapy shows promise for rare thymic cancer
Disease control OngoingThis phase II trial tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic carcinoma that had spread or couldn't be removed and no longer responded to standard chemotherapy. The goal was to see if the combination could shrink tumors or st…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 26, 2026 11:51 UTC
-
New combo therapy shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs—nivolumab (an immunotherapy that helps the immune system attack cancer) and temozolomide (a chemotherapy that kills cancer cells)—in people with advanced small-cell lung cancer or neuroendocrine tumors that have come back or stopped res…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Vitamin a derivative joins immunotherapy in fight against advanced lung cancer
Disease control OngoingThis early-stage trial tests a combination of all-trans retinoic acid (ATRA), a drug made from vitamin A, and atezolizumab, an immunotherapy, in 18 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 13, 2026 15:58 UTC